← Back to all substances
J

amoxicillin

248ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

1 INDICATIONS AND USAGE Amoxicillin and Clavulanate Potassium is indicated for the treatment of infections in adults and pediatric patients, due to susceptible isolates of the designated bacteria in the conditions listed below: Lower Respiratory Tract Infections - caused by beta‑lactamase–producing ...

Known as: AMOXICILLIN AND CLAVULANATE POTASSIUM
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
109,226
Total in FDA
88%
Serious Reports
64
Fatal Outcomes

Seriousness

Serious
440
Non-Serious
60

Sex Distribution

Male
214
Female
260
Unknown
26

Age Distribution

0-17
31
18-40
81
41-64
149
65-84
136
85+
21
Unknown
82

Outcomes

Recovered/Resolved
449
Recovering/Resolving
148
Not Recovered/Not Resolved
163
Recovered with Sequelae
16
Fatal
64
Unknown
947

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-423e13
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...